|
NXF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.271200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.751200E-01 |
| Normal-vs-Stage2 |
9.503200E-01 |
| Normal-vs-Stage3 |
3.006400E-01 |
| Normal-vs-Stage4 |
3.695700E-02 |
| Stage1-vs-Stage2 |
4.141000E-01 |
| Stage1-vs-Stage3 |
7.134400E-01 |
| Stage1-vs-Stage4 |
7.200300E-02 |
| Stage2-vs-Stage3 |
3.383000E-01 |
| Stage2-vs-Stage4 |
8.020000E-02 |
| Stage3-vs-Stage4 |
2.835800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.414200E-01 |
| Normal-vs-AfricanAmerican |
5.489200E-01 |
| Normal-vs-Asian |
7.251400E-01 |
| Caucasian-vs-AfricanAmerican |
8.381800E-01 |
| Caucasian-vs-Asian |
9.958600E-01 |
| AfricanAmerican-vs-Asian |
9.326000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.486380E-01 |
| Normal-vs-Female |
7.026400E-01 |
| Male-vs-Female |
3.838200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.884620E-01 |
| Normal-vs-Extreme_Weight |
3.771600E-01 |
| Normal-vs-Obese |
6.221800E-01 |
| Normal-vs-Extreme_Obese |
2.302000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.398800E-01 |
| Normal_Weight-vs-Obese |
3.299600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.151200E-01 |
| Extreme_Weight-vs-Obese |
5.459200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.122200E-01 |
| Obese-vs-Extreme_Obese |
3.247400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.462400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.869200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.290380E-01 |
| Normal-vs-Age(81-100Yrs) |
6.299600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.881200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.339600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.900000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.303700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.262100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.047600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.767000E-01 |
| Normal-VS-Type2 PRCC |
1.795790E-03 |
| Normal-VS-KIRP CIMP |
3.665000E-01 |
| Normal-VS-Unclassified PRCC |
6.276800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.16509999823234E-08 |
| Type1 PRCC-VS-KIRP CIMP |
2.977800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.614800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.362010E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.609200E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
9.572200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.804400E-02 |
| Normal-vs-N1 |
5.867200E-01 |
| Normal-vs-N2 |
1.420150E-04 |
| N0-vs-N1 |
2.556800E-01 |
| N0-vs-N2 |
2.322400E-03 |
| N1-vs-N2 |
8.598200E-04 |
|
|
